LVW Advisors LLC Purchases 269 Shares of Xylem Inc. (NYSE:XYL)

LVW Advisors LLC increased its position in Xylem Inc. (NYSE:XYL) by 6.5% in the 1st quarter, Holdings Channel reports. The firm owned 4,390 shares of the industrial products company’s stock after buying an additional 269 shares during the quarter. LVW Advisors LLC’s holdings in Xylem were worth $567,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Bruce G. Allen Investments LLC bought a new position in Xylem in the fourth quarter worth $27,000. Orion Capital Management LLC bought a new position in shares of Xylem during the third quarter valued at $48,000. Spire Wealth Management lifted its holdings in shares of Xylem by 370.9% during the fourth quarter. Spire Wealth Management now owns 485 shares of the industrial products company’s stock valued at $54,000 after acquiring an additional 382 shares during the period. Advantage Trust Co bought a new position in shares of Xylem during the fourth quarter valued at $57,000. Finally, Gradient Investments LLC lifted its holdings in shares of Xylem by 28.6% during the fourth quarter. Gradient Investments LLC now owns 576 shares of the industrial products company’s stock valued at $66,000 after acquiring an additional 128 shares during the period. 87.96% of the stock is owned by institutional investors.

Xylem Price Performance

Shares of XYL stock opened at $131.53 on Tuesday. The stock has a 50-day moving average price of $138.78 and a 200 day moving average price of $127.28. The company has a quick ratio of 1.22, a current ratio of 1.67 and a debt-to-equity ratio of 0.19. The firm has a market cap of $31.89 billion, a price-to-earnings ratio of 46.81, a PEG ratio of 2.40 and a beta of 1.04. Xylem Inc. has a 12 month low of $87.59 and a 12 month high of $146.08.

Xylem (NYSE:XYL) last announced its quarterly earnings data on Thursday, May 2nd. The industrial products company reported $0.90 EPS for the quarter, topping analysts’ consensus estimates of $0.84 by $0.06. The firm had revenue of $2.03 billion during the quarter, compared to analyst estimates of $2 billion. Xylem had a return on equity of 8.95% and a net margin of 8.34%. The company’s revenue was up 40.4% on a year-over-year basis. During the same period last year, the company earned $0.72 earnings per share. Research analysts expect that Xylem Inc. will post 4.25 EPS for the current year.

Xylem Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, June 27th. Stockholders of record on Thursday, May 30th were given a dividend of $0.36 per share. The ex-dividend date was Thursday, May 30th. This represents a $1.44 annualized dividend and a dividend yield of 1.09%. Xylem’s payout ratio is currently 51.25%.

Insider Transactions at Xylem

In other news, SVP Rodney Aulick sold 21,800 shares of the business’s stock in a transaction dated Wednesday, June 5th. The stock was sold at an average price of $139.01, for a total transaction of $3,030,418.00. Following the completion of the transaction, the senior vice president now directly owns 76,287 shares in the company, valued at approximately $10,604,655.87. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other news, SVP Rodney Aulick sold 21,800 shares of the business’s stock in a transaction dated Wednesday, June 5th. The stock was sold at an average price of $139.01, for a total transaction of $3,030,418.00. Following the completion of the transaction, the senior vice president now directly owns 76,287 shares in the company, valued at approximately $10,604,655.87. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CAO Geri-Michelle Mcshane sold 2,278 shares of the business’s stock in a transaction that occurred on Monday, June 10th. The shares were sold at an average price of $138.63, for a total value of $315,799.14. Following the completion of the transaction, the chief accounting officer now owns 3,536 shares of the company’s stock, valued at $490,195.68. The disclosure for this sale can be found here. Corporate insiders own 0.27% of the company’s stock.

Wall Street Analysts Forecast Growth

XYL has been the subject of a number of analyst reports. Oppenheimer lifted their price objective on Xylem from $147.00 to $152.00 and gave the company an “outperform” rating in a report on Friday, May 31st. BNP Paribas initiated coverage on Xylem in a report on Tuesday, March 12th. They set an “outperform” rating and a $150.00 price objective for the company. Royal Bank of Canada lifted their price target on Xylem from $157.00 to $162.00 and gave the company an “outperform” rating in a report on Friday, May 3rd. Argus lifted their price target on Xylem from $146.00 to $165.00 and gave the company a “buy” rating in a report on Wednesday, May 29th. Finally, Citigroup lifted their price target on Xylem from $126.00 to $139.00 and gave the company a “neutral” rating in a report on Monday, April 8th. Five research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $142.92.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.